287288
3-(2-噻吩基)-DL-丙氨酸
≥98%
别名:
2-氨基-3-(2-噻吩基)丙酸
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C7H9NO2S
化学文摘社编号:
分子量:
171.22
UNSPSC Code:
12352209
NACRES:
NA.22
PubChem Substance ID:
EC Number:
217-967-1
Beilstein/REAXYS Number:
82874
MDL number:
产品名称
3-(2-噻吩基)-DL-丙氨酸, ≥98%
InChI key
WTOFYLAWDLQMBZ-UHFFFAOYSA-N
InChI
1S/C7H9NO2S/c8-6(7(9)10)4-5-2-1-3-11-5/h1-3,6H,4,8H2,(H,9,10)
SMILES string
NC(Cc1cccs1)C(O)=O
assay
≥98%
form
powder
reaction suitability
reaction type: solution phase peptide synthesis
mp
275-277 °C (dec.) (lit.)
application(s)
peptide synthesis
Quality Level
正在寻找类似产品? 访问 产品对比指南
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
此项目有
K J Brown et al.
Antonie van Leeuwenhoek, 45(4), 531-546 (1979-01-01)
Mice fed beta-2-thienylalanine (beta-2-T) by oesophageal tube were no more susceptible to gastrointestinal tract colonization by Salmonella typhimurium or Shigella flexneri III than control mice fed water. In both beta-2-T-fed and water-fed groups, the increasing dosage of S. typhimurium, in
K J Brown et al.
Microbiology and immunology, 24(7), 603-615 (1980-01-01)
Growth comparisons were made, using Shigella, Escherichia, and Salmonella cultures, in liquid and agar-solidified defined media containing beta-2-thienylalanine (beta-2-t). The comparisons were performed to determine the nature of growth inhibition by beta-2-t under different physical growth conditions. In a plate
S Stoev et al.
Journal of peptide science : an official publication of the European Peptide Society, 5(3), 141-153 (1999-05-14)
We report the solid-phase synthesis and some pharmacological properties of 23 new analogs of arginine vasopressin (AVP) which have the Phe3 residue replaced by a broad variety of amino acids. Peptides 1-9 have at position 3: (1) the mixed aromatic/aliphatic
"Physiological phenylketonuria": a biochemical defect caused by delayed maturation of the phenylalanine hydroxylation pathway and by competition with the phenylalanine biosynthetic pathway.
K J Brown
Medical hypotheses, 6(2), 215-224 (1980-02-01)
D P Bedard et al.
Journal of bacteriology, 141(1), 100-105 (1980-01-01)
When treated with the amino acid analog beta-2-DL-thienylalanine, cells of the yeast Saccharomyces cerevisiae accumulated in the G1 portion of the cell cycle at the "start" event. This G1 arrest was accompanied by a rapid decrease in the rate of
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持